AbbVie Out $5.8 Billion After Scrapping Rova-T Program - BioSpace

-
AbbVie Out $5.8 Billion After Scrapping Rova-T Program  BioSpace

AbbVie announced that the Phase III MERU trial evaluating Rova-T as first-line maintenance therapy for advanced small-cell lung cancer, failed to demonstrate ...



Comments

Post a Comment

Popular posts from this blog

Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic ...

-
Image
stage 3 lung cancer spread to brain :: Article Creator Tracking Lung Cancer's Path It's common for lung cancer to metastasize, or spread. In fact, 57 percent of lung cancer patients are diagnosed when the cancer has already metastasized, according to an editorial in the Annals of Cancer Epidemiology. [1] Lung cancer also has a preferred path, traveling most often to the bones, brain, adrenal glands, and liver. [2] [3] Why Does Lung Cancer Spread So Easily? Lung cancer may metastasize readily because the lungs are a cellular traffic hub of the body. "The job of the airway is to deliver oxygen to all of your cells, so it's easy for cancer cells to get from the airway lining to the blood and spread to other organs," says Paul Bunn, MD, a professor of medical oncology at the University of Colorado School of Medicine in Aurora. Why Do Lung Cancer Cells Spread to Certain Organs? "Some organs produce a cellular si...
Read more

Stage 4 Lung Cancer Life Expectancy

-
Image
stage 3c lung cancer prognosis :: Article Creator Experimental Drugs Could Help Lung Cancer Treatment Research Enter A New Era More people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs that target molecular alterations in tumor cells, with less need for chemotherapy, following results of multiple clinical trials reported for the first time in late-breaking presentations at the ESMO Congress 2023. Better outcomes were achieved with combinations of experimental new drugs targeting common and rare tumor mutations than with standard treatments, with improvements seen in both early and late-stage NSCLC—the type of lung cancer responsible for approximately eight out of 10 cases of the disease. "The results are very impressive and mean that we can expect major changes in first-line treatment for patients with NSCLC with these targetable tumor cell alterations, and in the way we care for patients whose previous tr...
Read more

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...

-
Image
kathy lung cancer :: Article Creator Kathy Griffin Reveals Theory Her Lung Cancer Was Caused By Poisoning Kathy Griffin Reveals Theory Her Lung Cancer Was Caused by Poisoning SHARE SHARE TWEET SHARE EMAIL What to watch next Prince Harry Ghostwriter's Poorly Timed Swipe At Royals Newsweek Experts Say Russia Could Be In Trouble As Elites Look Escape 'Sinking Ship' Newsweek Jim Jordan's FBI Whistleblower Hearing Descends Into Chaos Newsweek Adidas Boycott Calls Grow Over Women's Swimsuit Modeled By Biological Male Newsweek General Testifies For House Armed Services Committee Newsweek Israeli Nationalist Gather For 'Flag March' In Jerusalem Newsweek Marjorie Taylor Greene Calls For Trump-Appointed FBI Director's Impeachment Newsweek Declawed Rescue Cat Dumped at Shelter Finally Gets A Name: 'Suits Him' Newsw...
Read more